combine@alvar.ug

The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs

The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs

Show simple record

dc.contributor.author Ba-Nguz, Antoinette
dc.contributor.author Adjagba, Alex
dc.contributor.author Hendrarto, Toto Wisnu
dc.contributor.author Sewankambo, Nelson K.
dc.contributor.author Nalwadda, Celia
dc.contributor.author Kisakye, Annette
dc.date.accessioned 2021-01-01T21:58:15Z
dc.date.available 2021-01-01T21:58:15Z
dc.date.issued 2017
dc.identifier.issn 0022-1899
dc.identifier.uri http://combine.alvar.ug/handle/1/48232
dc.description.abstract Background. National Immunization Technical Advisory Groups (NITAGs) are established by national authorities to provide them with independent, bias-free, objective, and evidence-based advice on vaccines and immunization challenges. As of December 2015, 125 countries have reported having set up an NITAG. The Health Policy and Institutional Development Center at the Agence de Medecine Preventive, a World Health Organization (WHO) Collaborative Center for evidence-informed immunization, through its Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative project, provides assistance to low-and middle-income countries in the establishment and strengthening of their NITAGs. The Indonesian NITAG (ITAGI) was formed in December 2006 and Uganda's (UNITAG) was formed in November 2014. Both Uganda and Indonesia have introduced inactivated polio vaccine (IPV) as part of the Global Polio Eradication and Endgame Strategic Plan (the Endgame plan). The authors reflect on the process and the role played by NITAGs in the introduction of IPV in the routine immunization program and the lessons learned. Methods. This commentary is a reflection of the authors' experience on NITAG's role as observed in 2 particular local settings and applied to a global public health issue, the polio eradication Endgame plan. The reflection is backed up by the relevant (policy and technical) documents on polio eradication, along with minutes and reports from countries' ministries of health, immunization programs, WHO, and NITAGs. Results. NITAGs are valuable tools for ministries of health to ensure sustainable, evidence-informed immunization policies that are trusted and accepted by their communities. Early engagement with NITAGs also ensures that the adoption of strategies addressing global public health threats at the country level reinforces the national immunization programs. On the other end, when NITAGs are proactive and forward-thinking, they can contribute to a smooth and effective introduction of the above-mentioned strategies. Time and resources are key factors to ensure optimal performance of NITAGs.
dc.description.sponsorship Bill and Melinda Gates FoundationBill & Melinda Gates Foundation
dc.description.sponsorship Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA
dc.language English
dc.publisher OXFORD UNIV PRESS INC
dc.relation.ispartof Journal of Infectious Diseases
dc.subject Immunisation Advisory Groups
dc.subject Indonesia
dc.subject Uganda
dc.subject Sivac Initiative
dc.subject Inactivated Polio Vaccine
dc.title The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs
dc.type Article
dc.identifier.isi 000405094500015
dc.identifier.doi 10.1093/infdis/jiw601
dc.identifier.pmid 28838176
dc.publisher.city CARY
dc.publisher.address JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
dc.identifier.eissn 1537-6613
dc.identifier.volume 216
dc.identifier.spage S109
dc.identifier.epage S113
dc.subject.wc Immunology
dc.subject.wc Infectious Diseases
dc.subject.wc Microbiology
dc.subject.sc Immunology
dc.subject.sc Infectious Diseases
dc.subject.sc Microbiology
dc.description.oa Green Published
dc.description.oa Other Gold
dc.description.pages 5
dc.subject.kwp Establishment
dc.description.affiliation Agence Med Prevent, Hlth Policy & Inst Ctr, Paris, France
dc.description.affiliation Indonesia NITAG, Paris, France
dc.description.affiliation Uganda Natl Acad Sci, Kampala, Uganda
dc.description.affiliation Uganda NITAG, Kampala, Uganda
dc.description.affiliation Makerere Univ, Coll Hlth Sci Uganda, Kampala, Uganda
dc.description.affiliation WHO, Uganda Country Off, Kampala, Uganda
dc.description.email aba-nguz@aamp.org
dc.description.corr Ba-Nguz, A (corresponding author), POB 657, Nairobi 00606, Kenya.


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account